Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin
<p>Abstract</p> <p>The rapid antibiotic resistance development has created a major demand for new antimicrobial agents that can combat resistant strains such as methicillin-resistant <it>S. aureus </it>(MRSA). Until a short time ago, the glycopeptide vancomycin was the...
Main Authors: | Estes Kerry S, Derendorf Hartmut |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-11-01
|
Series: | European Journal of Medical Research |
Online Access: | http://www.eurjmedres.com/content/15/12/533 |
Similar Items
-
Investigation of linezolid, tigecycline and daptomycin susceptibility in vancomycin-resistant enterococci using E-test method
by: Mehmet Parlak, et al.
Published: (2014-09-01) -
Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin
by: Eckmann Christian, et al.
Published: (2010-11-01) -
Comparison of linezolid and daptomycin for the treatment of vancomycin-resistant enterococcal bacteremia
by: Navaneeth Narayanan, et al.
Published: (2019-02-01) -
Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol
by: Zarogoulidis P, et al.
Published: (2014-08-01) -
Biomechanical comparison of tigecycline loaded bone cement with vancomycin and daptomycin loaded bone cements
by: Sedit Kıvanç Muratlı, et al.
Published: (2020-09-01)